Kagan, Risa <br/><br/>
Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo.  [electronic resource] 

 -  Postgraduate medicine  Nov 2018 
 - 687-693 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1941-9260 
<br/><br/><label>Standard No.: </label>10.1080/00325481.2018.1520046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Estrogen Replacement Therapy--adverse effects<br/>Estrogens, Conjugated (USP)--administration & dosage<br/>Female<br/>Humans<br/>Indoles--administration & dosage<br/>Medroxyprogesterone Acetate--administration & dosage<br/>Middle Aged<br/>Postmenopause<br/>Selective Estrogen Receptor Modulators--administration & dosage<br/>Uterine Hemorrhage--chemically induced